To determine the origin of peripheral blood mononulclear cells (PBMC) that activate regulatory T cells in anterior chamber-associated immune deviation (ACAID), fluorescein-labeled PBMC were intravenously injected into mice before the mice receivedanintracameralinjectionofantigen.Six-24hrafterintracameralinjection,fluorescein-labeledPBMCincreasedintheiris. Twenty-four-48hrlabeledcellsdecreasedintheirisandincreasedinthethymusandspleen.TheentryofthelabeledPBMCintothe anteriorchamberandsubsequentproductionofPBMCthattransferACAIDrequiredtheexpressionofCCR2bythePBMCandthe productionofthechemokineCCL2bytherecipientofthePBMC.Theresultssuggestthattheintracameralinjectionofantigeninduces i)theinfiltrationofF4/80 + PBMCintotheAC,ii)wherethesePBMCareconvertedtoaregulatoryphenotype,andiii)recirculateto activateTcellsthatsuppresscell-mediatedimmunity.
Introduction
The "immune privilege" of the eye is conferred by cellular and environmental factors that limit the ability of innate and adaptive immune mechanisms to impose "collateral damage" on sensitive ocular tissue. [1] [2] [3] [4] Additionally, the injection of antigen into the anterior chamber induces a systemic suppression of both cell mediated immunity and the antigeninduced production of IgG2 (complement-fixing) antibodies.
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F4/80
+ peripheral blood mononuclear cells (PBMC) and iris cells recovered from mice receiving the intracameral injection of antigen (AC-PBMC) i) induce anterior chamber-associated immune deviation (ACAID);
1,2,4-10 ii) home to the thymus 8 and the spleen 5,6,10 whereregulatoryTcells thatinduceoreffecttheantigen-specificsuppression ofanimmuneresponsearegenerated.
Circulating, ACAID-inducing F4/80 + cells are thoughttobederivedfromtheirisandciliarybody. 1, 2, 4, 5 ThisisbasedonobservationsthatF4/80 + iris cells recoveredfrommicethatreceivedan intracameralinjection of antigen confer an immunosuppressive phenotype on systemic F4/80 + cells in vitro. 5, 9 Moreover, treatment of systemic F4/80 + cells with TGF-β and antigen or aqeuous humor in vitro induces an immunosuppressive phenotype similar to PBMC recovered from mice that receivedanintracameralinjectionofantigen. 11, 12 However,theoutwardpassageofresidentiris/ciliarybody F4/80 + cellstothecirculationhasbeenquestioned. [13] [14] [15] Accordingly, the "delivery" of intracameral antigen to the periphery and the origin of the ACAID-inducing PBMC is not clear. Therefore, detailed information about the events that occur in the anterior chamber immediatelypostintracameralinjectioncouldprovide insight into the nature of the generation of the ACAIDinducing"signal"thatinturninfluencessystemicimmunity.Becausetheegressofiris-residentF4/80 + cells has notbeendemonstrated,wereasonedthatfollowingan intracameralinjectionofantigen,thereisaninfluxof circulating F4/80 + cells into the anterior chamber in responsetotheinjection.Theseinfiltratedcellswould beexposedtoTGF-βandtoiris/ciliarybodycellsthat provideantigen.Conceivably,theF4/80 + cellsthatinfiltratedtheanteriorchamberwouldthenreenterthecirculationandhometothethymusandspleenwherethey interactwithandinduceregulatoryTcells.
Here we demonstrate that an intracameral injection of antigen induces a CCR2-dependant entry of circulatingF4/80 + cells into the anterior chamber that associate with the iris. These cells then re-enter the circulation and home to the thymus and spleen. The induction of the suppression of delayed-type hypersensitivity to the intracameral antigen by circulating monocytes recovered from mice receiving an intracameralinjectionofantigenisdependentontheinflux ofcirculatingF4/80 + cells to the anterior chamber and subsequent recirculation to the thymus and spleen. Therefore,weconcludethatACAIDisaconsequence ofaresponsetotheinjectionofantigenintotheanterior chamber that utilizes environmental elements of ocular immune privilege to activate systemic immunoregulatorycells.
Matrials and Methods Mice
Female BALB/c, and C57Bl/6 mice 6-8 wks old were purchased from Charles River Labor atories, Jackson,MA.,HarlanLaboratories, Frederick,MarylandorJacksonLaboratories,BarHarbor,Me.CCR2 -/-(B6.129S4-Ccr2tm1Ifc/J),CCR5-/-(B6.129P2-Ccr5tm1Kuz/J) MCP-1(CCL2)-/-(B6.129S4-Ccl2tm1Rol/J) mice were purchased from Jackson Laboratories.The mice were maintained in the Center for Laboratory Animal Care of the University of Connecticut Health Center. All work with animals was approved previously by the University of Connecticut Health Center Animal Care Committee (ACC2007-369).Allanimalsweretreatedaccordingto theARVOStatementfortheUseofAnimalsinOphthalmicandVisionResearch.
Antigens
2,4,6 trinitrobenzene sulphonic acid (TNP), bovine serum albumin (BSA) and ovalbumin (OVA) were purchased from the Sigma Chemical Company, (StLouisMO).TrinitrophenylatedBSA(TNP-BSA) waspreparedasdescribed. 7 Picryl chloride (PCl), an analogueforTNP,2-chloro1.3.5-trinitrobenzenewas purchased as 2-chloro-5-triphtane from Chemical AltaLtd(Edmonton,Alberta,Canada).
immunization, elicitation and measurement of Delayed-Type hypersensitivity (DTh)
Mice were sensitized by the subcutaneous (sc) injectionof200µgTNP-BSAorovalbumin(OVA) in 100 µl 1:1 phosphate-buffered saline (PBS, 7.2) and Complete Freund's Adjuvant (CFA, Sigma, StLouisMO).DTHwasmeasured7daysafterthe micewereimmunized.SensitizedornaïveMicewere anesthetizedwithketamine/xylazine(pleaseseeanteriorchamberinjectionfordose)andfootpadthickness was measured in triplicate with a digital engineer's micrometer (Mitatoyo, Tokyo, Japan) before the footpads were challenged with antigen or vehicle. TNP-BSA-sensitizedornaïvemicereceiveanepicu-taneous application of 15 µl 1% picryl chloride (PCl inacetone:oliveoil4:1)toonefootpad,vehicleonly to the other footpad and the thickness of the footpad receiving PCl and the non-antigen challenged footpad wasmeasured24hrlater.DTHtoOVAwasmeasured by the intradermal (id) injection of 100 µg OVA in 25µlPBS.Micrometersofswellingweredetermined bycomputingthedifferenceinthicknessbetweenthe challenged and vehicle-challenged footpad before andafterchallenge.
Preparation of cells Spleen cells, thymus cells
Mice were euthanized by cervical dislocation. Spleens and thymi are removed from the mice, pooled, diced and expressed through a 70-µm nylon mesh (BD Falcon, Bedford, MA, USA) with a 1-ml syringe plunger into RPMI-1640medium(4°C,Invitrogen,Carlsbad,CA). The cells were washed 2-3X and suspended in PBS. 
Results
F4/80
+ PBMc migrate to the iris, thymus, and spleen after intracameral injection
+ cells that transfer the suppression of DTH when injected into naïve or immunized mice have been recovered from the irides of mice that received anintracameralinjectionofantigen. 4, 6, 7, 9 To test our hypothesisthatintracameralinjectionrecruitsF4/80 + PBMCtotheanteriorchamber,naïvemicereceived ivPBMClabeledwithCFSE.Theseintroduced,circulating CFSE-PBMC could be tracked to the iris, thymusandspleenfollowingintracameralinjection. Approximately 7.4% of the CFSE-labeled cells had a forward scatter (FSC) consistent with monocytes. ThemajorityofthePBMClabeledwellwithCFSE andsixteenpercentoftheCFSE-labeledPBMCwere stained by antibodies to F4/80 or CD11b ( ,CFSE-labeledcellsincreased180or230%in the iris, spleen and thymus respectively after an intracameral injection of antigen. There was no increase in the thymus of CFSE-labeled cells in the absence ofanintracameralinjection (Fig.3A) .CSFE-labeled, F4/80 + cellsincreasedintheirisapproximately40% 24 hr after an insertion of the 30 g needle into the anterior chamber without an injection of PBS and a 54%increasewithan intracameralinjectionofPBS. (Fig. 3B ). In addition, we observed a significant increase in unlabled, F4/80 + cellsintheiris,thymusandspleen24hraftertheintra-cameral injection of antigen (Fig. 3C) Kinetics of the increase of F4/80 + PBMc in the iris, thymus, and spleen after the intracameral injection of antigen
To determine the duration of the increase in monocytes in the anterior chamber induced by the intracameralinjectionofantigenandapossibletransitofthese cells from the eye to the periphery, a time-dependent change in CFSE-labeled F4/80 + PBMC in the iris, thymusandspleenaftertheintracameralinjectionof antigen was investigated.Thymi, spleens and irides were recovered from mice receiving CFSE-labeled PBMC 1-168 hr after the intracameral injection of TNP-BSA. As shown in Figure 4 , CFSE-labeled, F4/80 + PBMC increased 3-fold in the iris 6 hr after theintracameralinjectionofantigen.However,6hr aftertheintracameralinjectiontherewasanincrease inCFSE-labeledcellsintheirisandthymusbutnot the spleen compared to mice that received no intracameral injection. Twenty-four hr after the intracameral injection of antigen there was still a 3-fold increase in CFSE-labeled PBMC recovered from the iris but also a 4-fold increase in CFSE-labeled, F4/80
+ cells continued to increase in the thymus 72 hr after the intracameral injection of TNP-BSA.Three-5daysaftertheintracameralinjec-tionof TNP-BSAthenumberofCFSE-labeledPBMC inthethymusdecreased. homing of F4/80 + PBMc to the iris after the intracameral injection of antigen is dependent on the chemokine receptor ccr2 To investigate the role of chemokines in the infiltration of PBMC to the anterior chamber after the intracameral injection of antigen, we first investigated the levelsof chemokine receptorsintheiris.Twenty-four hraftertheintracameralinjectionofTNP-BSA,irides were recovered and RNA from the iris cells and cells fromnaïvemiceweresubjectedtoreal-timePCRand probedformRNAforthechemokinereceptorsCCR2, CCR5,knowntoparticipateintherecruitmentofmonocytesduringinflammation. 16 Mice receiving an intracameralinjectionofOVAshowedasignificantincrease inmRNAforCCR2andCCR5 (Fig.5) .FlowcytometryofcirculatingandinfiltratedPBMCdemonstrated thatbothpopulationsofcellsexpressCCR5andCCR2. However,mRNAforCCR6andCCR7wasnotdetected (datanotshown).Theseresultssuggestedthateitherthe productionofCCR2andCCR5wasinducediniriscells aftertheintracameralinjectionofantigenor,monocytes expressingCCR2andCCR5infiltratedtheiris.
PBMc that transfer the suppression of DTh after the intracameral injection of antigen (Ac-PBMc) are recovered from ccr5 -/-but not ccr2 -/-mice AroleforCCR5orCCR2chemokinereceptorsinthe migrationofF4/80
β-Actin Naïve Figure 5 . recovery of increased mrnA for ccr2 and ccr5 from the iris after the intracameral injection of antigen. rnA was obtained from 10 irides of c57BL6 naïve mice and 16 hr after mice received an intracameral injection of OVA. rnA was reverse-transcribed using random hexamers. Primers were used to amplify ccr2, ccr5 and β-actin transcripts from cDnA. Serial doubling dilutions of the cDnA were done, left lane = 1:10. The final comparison was done in the linear range of dilutions of template DnA.
bylabelingPBMCfromCCR2-/-orCCR5-/-mice withCFSE.TheseCFSE-PBMCwereinjectedivinto C57BL/6WTmice.Onehraftertheivinjectionof theCFSE-labeledPBMC,therecipientsreceivedan intracameralinjectionofTNP-BSA.Irides,thymiand spleens were removed 20-24 hr after the intracameral injection of TNP-BSA. Intravenously injected F4/80 + , CFSE-labeled PBMC from CCR5 -/-but notCCR2-/-mice increased in the irides, thymi and spleensofmicethatreceivedanintracameralinjection of TNP-BSA (Fig. 6) . However, CFSE-labeled PBMCweredetectedinthespleensofwildtype(WT) mice that received an iv injection of CFSE-PBMC recoveredfrom both CCR2 -/-or CCR5 -/-mice, However,therewasnoincreaseinthespleeninrecipientsofCFSE-labeledPBMCfromCCR2-/-mice. These results suggest that the increased migration of F4/80 + PBMC to the anterior chamber after the intracameralinjectionofantigenandsubsequentincrease in the spleen is dependent on the chemokine receptorCCR2.However,CFSE-labeledCCR2 -PBMC do migratetothespleenafterivinjectiononly.
PBMCrecovered24hraftertheintracameralinjec-tion of antigen (AC-PBMC) induce the suppression of DTHwhentransferredtonaïveorimmunizedrecipi-ents. [4] [5] [6] [7] [8] [9] Since PBMC from CCR2 -/-mice do not infiltrate the anterior chamber after the intracameral injection of antigen (Fig. 6) weinvestigatedwhether AC-PBMC recovered from CCR2 -/-or CCR5 -/-micetransfertheinductionofthe suppressionofDTH. PBMCrecoveredfromCCR2orCCR5-/-mice (AC-PBMC)24hrafterthedonorsreceivedanintracameral injectionofTNP-BSAwereinjectedivintonaïveWT mice.OneweekaftertheinjectionoftheAC-PBMC, the recipients were immunized withTNP-BSA/CFA. Oneweekafterimmunizing,footpadsofthesemiceand immunized mice that did not receive the AC-PBMC were challenged with PCl. DTH was significantly reduced inWT mice receivingAC-PBMC recovered fromWTorCCR5-/-micebutwasnotsuppressedin WTmicereceivingAC-PBMCfromCCR2-/-mice (Fig.7) .Therefore,CCR2-/-PBMCdonotinfiltrate theanteriorchamberaftertheintracameralinjectionof antigenandCCR2-/-mice do not produce AC-PBMC thatinducethesuppressionofDTH.
PBMc that transfer the suppression of DTh after the intracameral injection of antigen (Ac-PBMc) are not produced by ccL2 -/-mice BecauseAC-PBMCwerenotproducedbyCCR2-/-micethatreceivedanintracameralinjectionofantigen (Fig.7) we investigated whether CCR2 + PBMC (WT)wouldmigratetotheirisinmicelackingCCL2, one of the ligands for CCR2. Accordingly, CFSElabeledWTPBMCwereinjectedivintoCCL2-/-or WT mice. One hour later the mice received an intracameral injection of TNP-BSA. Irides, spleens andthymiwererecovered24hraftertheintracameral . The expression of ccr2 by PBMc is required for migration of PBMc to the iris after the intracameral injection of antigen. One hr after naïve c57BL/6 mice were injected iv with cFSE-labeled PBMc from naïve WT, ccr5 -/-or ccr2 -/-mice, the mice received an intracameral injection of TnP-BSA. Twenty-four hr after the intracameral injection irides were removed and cell suspensions stained with phycoerythrin anti-F4/80 antibody. The cells were analyzed by flow cytometry. % increase F4/80, CFSE + = increase in F4/80, cFSE + cells from iv only calculated as in Figure 3A . The data represents the mean ± S.E.M. of 3-5 experiments. note: *P , 0.01. 
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100 120 Figure 7 . The expression of ccr2 is required for the activation of AcPBMc that transfer the suppression of DTh. PBMc recovered 24 hr after naïve WT, ccr5 -/-(A) or ccr2 -/-(B) mice received an intracameral injection of TnP-BSA were injected iv into naïve recipient c57BL/6 mice. The recipients were immunized with TnP-BSA and cFA one week later and one week pi a footpad was challenged with epicutaneous Pcl. Swelling was measured 24 and 48 hr after challenge. Data represents the mean ± S.E.M/of eight mice/group, 3 experiments. note: *P , 0.02.
injection.Cellsuspensionswerepreparedandstained with PE anti-F4/80 antibody. Significantly fewer CFSE-labeled cells infiltrating the irides of ACinjectedmicewereobservedinCCL2-/-recipients (Fig.8) .
To determine whether CCL2 -/-mice produce circulatingAC-PBMC,PBMCwererecoveredfrom CCL2-/-miceapproximately24hraftertheintra-cameralinjectionofOVA.Thesecellswereinjected ivintonaïveWTmice.Oneweekaftertheinjection ofAC-PBMC, these recipient mice and naïve mice were then immunized with OVA and CFA. DTH to OVAwasdeterminedoneweekafterthemicewere immunized. DTH to OVA was reduced significantly in OVA-immunized WT mice that received AC-PBMC from WT but not CCL2 -/-mice (Fig.9) .SimilarlyAC-PBMCrecoveredfromCCL2 -/-mice receiving intracameral TNP-BSA did 
Discussion
AlthoughthephenomenonofACAIDhasbeenknown for20+ years, events that occur in the eye that induce ACAIDarenotclear.Indeed,therearestillquestions as to the nature of the eye-derived immunosuppressivesignal.Informationontheoculareventsrequired togeneratetheACAID-inducingsignalwillilluminate theeye-systemicconnectionthatinducesACAID.
Antigen is readily distributed to the circulation aftertheintracameralinjectionoftheantigen,similar to antigen injected intravenously 1, 8, [13] [14] [15] except that antigen injected into the anterior chamber is detectedinthethymuswithin24hraftertheintra-cameral injection 8 Circulating antigen does not enter the thymus but may be delivered to the thymusbycirculatingmonocyticcells. 17 Moreover, the cell-associated antigen in the periphery may be "processed" antigen presented by MHC class II or Qa-1 or CD-1 that cannot be detected by antibodies orlabeledantigen.Sincethemigrationofmonocytic cells resident in the iris and ciliary body has not been demonstrated, we hypothesized that circulating monocytic cells might enter the anterior chamberinresponsetotheinjection.Indeed,amonocytic infiltrationintotheanteriorchamberafterintracameralinjectionhasbeenreported. 18 Oncethesecells entertheanteriorchambertheycouldinteractwith irisantigenpresentingcells. 11, 13, 19 These monocytic cellsrecoverantigenattheirisandwouldbeconverted to a suppressive phenotype by TGF-β (in aqueous humor) as demonstrated in vitro. 5 In other words, our results suggest that the induction of ACAID uses elements of ocular immune privilege to generate a systemic signal for the generation of regulatoryTcells.
The intracameral injection of antigen induces an increaseofTNF-α in aqueous humor 20 suggesting that theinjectioninducesamoderateinflammatoryevent intheanteriorchamber.Moreover,theproductionof TNF-α is required to induce ACAID. 20, 21 Because the induction of ACAID by an intracameral injection of bovine serum albumin required TNF-α and was dependent on the gauge of the needle used for the intracameral injection 20 these authors suggested thatACAIDistheresultofaresponsetotheinjection intheanteriorchamber.AlthoughmonocyticF4/80 + cells resident in the iris present antigen, 15, 19 the ability of these cells to emigrate from the iris (and ciliarybody)hasnotbeendemonstrated. [13] [14] [15] It could be argued that since less than 100 F4/80
+ cells treated with TGF-β and antigen in vitro induce the suppression of DTH, 2 a small, undetectable number of residentantigenpresentingcellsintheiriscouldexit from the eye and induce the systemic suppression of DTH. Therefore, it is likely that circulating, F4/80 + cells that transmit the suppression of DTH are bearingtheantigeninjectedintotheanteriorchamber. Wefocusedourphenotypingofthemonocyticcells thatinfiltratedtheanteriorchamberonF4/80because iriscellsbearingF4/80recoveredfrommicereceiv-ing an intracameral injection of antigen induce the suppressionofDTHwhentransferredtoimmunized mice. 4, 7 Infact,theexpressionofF4/80isrequiredfor regulatory macrophages to induce the suppression of DTH. 22 To track the migration of circulating monocytes after the intracameral injection of antigen we injectedCFSE-labeledPBMCivbeforetheintracameralinjection.ThemigrationoftheseCFSE-labeled cells provided direct evidence that circulating monocytes enter the anterior chamber after intracameral injection.A needle stick only, the injection of PBS only or antigen and PBS all increased the influx of F4/80 + PBMC into the anterior chamber. However, quantitatively,theinfluxofthesecellsafterintracameral injection is: PBMC + antigen injection . PBS injection only . injection only. In addition, we observedanincreaseinunlabeled,F4/80 +low cells in the iris, spleen and thymus. The increase of these cells in the blood, and spleen has been described. 10 Therefore,theincreasedinfluxofPBMCisalikely responsetotheintracameralinjection.However,this responsetotheinjectionistransient.Strong,persistentinflammationsuchasthatgeneratedby infection . ccL2 -/-mice do not produce suppressive PBMc after the intracameral injection of antigen. PBMc were recovered from ccL2 -/-and WT (c57BL/6) mice 24 hr after the mice received an intracameral injection of OVA were injected iv into c57BL/6 WT mice. One week later the recipients of the PBMc and naïve mice were immunized with OVA. One week pi footpads of the mice were challenged with OVA. The increment in swelling was measured 24 and 48 hr after challenge. Data is the mean swelling ± S.E.M. for 4-8 mice/group. note: *P , 0.05.
AC-PBMC Injected
or a burn could prevent the induction of ACAID regulatory monocytic cells. 23, 24 A corneal transplant induces an unusual CD4 + regulatory T cell that has properties similar the CD8 + T regulatory T cell induced byACAID. 25 This cell may be induced by a chronic presence of antigen (even self antigen). 26 However,amoderateinflammation-inducinginfiltrationofPBMCmayalsoinduceACAID.
The more than 4-fold increase in CFSE-labeled, F4/80 + cellsinthespleenaftertheintracameralinjection of antigen is greater than the 60% increase in these cells in the spleen after intracameral injection describedpreviously. 10 TheCFSE-labeledcellswere introducedrecentlyandrepresentafinitenumberof cells.WeobservedthattheincreaseinsplenicunlabeledF4/80 + spleencellsafterintracameralinjection was60%,similartothatobservedbyFaunceetal.
10 It isunlikelythatthedecreaseinCFSE-labelediriscells wasduetoalossinfluorescence.Theegressofthese cells from the anterior chamber may be via the Canal ofSchlemmand/ortheuveoscleralroute.
14 Moreover, irisF4/80 + cells and PBMC recovered from the iris or blood(respectively)24hraftertheintracameralinjec-tion of antigen also home to the thymus and spleen 27 suggesting further that PBMC recruited to the iris aftertheintracameralinjectionofantigenrecirculate overathree-dayperiod.
The requirement for the expression of CCR2 by F4/80 + PBMC to infiltrate the anterior chamber after intracameral injection suggests that the F4/80 + cells are attracted by the CCR2 chemokine ligands CCL2 and/or CCL7. MCP-1 does attract inflammatory cellsinuveitisandinfection. 28, 29 Moreover, there is a marked reduction in the infiltration of CFSE-labeled PBMCintotheanteriorchamberafterCCL2-/-mice receivedanintracameralinjectionofantigenalthough CCR2 -/-monocytes do migrate to the spleen. PerhapsthemigrationofPBMCtotheirisinCCL2-/-micereceivinganintracameralinjectionofantigenis alsoduetoCCL7(MCP-3),anotherligandforCCR2. PBMCrecoveredfromCCR2-/-orCCL2-/-mice thatreceivedanintracameralinjectionofantigenfailto transferthesuppressionofDTHtothatantigenwhen injected iv into WT mice. Because these PBMC do notinfiltratetheanteriorchamberaftertheintracameralinjectionofantigenitisunlikelythatthesePBMC accessedantigenorwereinfluencedbytheimmuneprivileged environment of the anterior chamber.
Althoughrobust inflammationcoulddiminishorprevent ACAID, 2, 23, 24 the required infiltration of PBMC into the anterior chamber in response to the chemokine CCL2 suggests thatACAID may be a "by-product" ofanocularresponsetoinjurythatinducesamoderate, transient inflammation in response to the injection. Here elements of the peripheral inflammatory/ adaptiveimmunesystemareinfluencedbyfactorsinan immune-privilegedenvironment,therebyextendingan immunosuppressiveinfluencetotheperiphery.Experimentsareinprogresstoinvestigatethishypothesis. 
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